![](/img/cover-not-exists.png)
PWE-253â Adalimumab improves health-related quality of life for 52â weeks in patients with ulcerative colitis: Abstract PWE-253 Table 1
Sandborn, W J, Van Assche, G, Thakkar, R B, Lazar, A, Kron, M, Yang, M, Patel, S P, Chao, J, Mulani, P MVolume:
61
Journal:
Gut
DOI:
10.1136/gutjnl-2012-302514d.253
Date:
July, 2012
File:
PDF, 80 KB
2012